From: Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects
Total number | % of total | |
---|---|---|
Icterus of unknown cause | 19 | 19.19 % |
Trisomy 21 | 16 | 16.16 % |
Cholestasis of prematurity | 15 | 15.15 % |
Sujcts too ill to transport to scanner, died before the study, or parents declined diagnostic procedures | 15 | 15.15 % |
Undiagnosed subjects who did not return for follow-up | 8 | 8.08 % |
Neonatal systemic lupus erythematosus | 5 | 5.05 % |
Mitochondrial dysfunction | 3 | 3.03 % |
Neonatal sclerosing cholangitis | 2 | 2.02 % |
Common bile duct (CBD) stones | 2 | 2.02 % |
Congenital hepatic fibrosis | 1 | 1.01 % |
Portal venous thrombosis | 1 | 1.01 % |
Aagenae’s syndrome | 1 | 1.01 % |
Carbohydrate deficient glycoprotein | 1 | 1.01 % |
Familial hemophagocytic lymphohistiocytosis | 1 | 1.01 % |
Annular pancreas | 1 | 1.01 % |
Arthrogryposis syndrome | 1 | 1.01 % |
Histiocytosis X | 1 | 1.01 % |
Stenosis of the choledochojejunal junction | 1 | 1.01 % |
Hydrocephalus | 1 | 1.01 % |
Cleidocranial dysostosis | 1 | 1.01 % |
Cardiomyopathy/hydrops fetalis | 1 | 1.01 % |
Renal tubular acidosis | 1 | 1.01 % |
Spontaneous perforation of the CBD | 1 | 1.01 % |
Total | 99 | 100.00 % |